Dysphagia in Parkinson's Disease.

Area of Science:

• Neurology
• Gastroenterology
• Speech and Language Pathology

Background:

• Dysphagia affects over 80% of Parkinson's disease (PD) patients, significantly reducing quality of life.
• Swallowing impairment in PD leads to malnutrition, aspiration pneumonia, and medication adherence issues.
• The pathophysiology of PD-associated dysphagia involves complex dopaminergic and non-dopaminergic mechanisms.

Purpose of the Study:

• To provide a comprehensive overview of the epidemiology, pathophysiology, diagnosis, and treatment of dysphagia in Parkinson's disease.
• To assist clinicians in managing PD-related swallowing difficulties.
• To identify areas for future clinical research in PD dysphagia.

Main Methods:

• Review of current literature on Parkinson's disease and dysphagia.
• Discussion of diagnostic tools including modified water tests, questionnaires, fiberoptic endoscopic evaluation of swallowing (FEES), videofluoroscopic swallowing study (VFSS), and high-resolution manometry.
• Analysis of therapeutic strategies, including pharmacological interventions and speech and language therapy (SLT).

Main Results:

• Clinical assessment of dysphagia in PD is challenging; instrumental evaluations like FEES and VFSS are gold standards for detecting aspiration.
• Dysphagia patterns vary, requiring individualized SLT interventions.
• Optimizing dopaminergic medication can help fluctuating dysphagia; intensive expiratory muscle strength training shows promise.

Conclusions:

• Accurate diagnosis of PD-associated dysphagia relies on objective instrumental assessments.
• Treatment should be multimodal, combining optimized medication with tailored speech and language therapy.
• Further research is needed to fully understand and effectively manage PD-related swallowing impairments.